056090 — Innosys Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Innosys Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1,890	-12,283	-5,215	-18,808	1,306
Depreciation
Amortisation
Non-Cash Items	1,606	9,915	4,818	20,391	-4,863
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-4,066	2,015	-481	-9,184	-756
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-2,105	2,053	1,285	-5,400	-2,460
Capital Expenditures	-711	-205	-862	-820	-1,590
Purchase of Fixed Assets
Other Investing Cash Flow Items	239	-1,416	-3,789	-51,436	56,615
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-472	-1,620	-4,651	-52,255	55,025
Financing Cash Flow Items	—	—	—	5,300	-4,039
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-4,514	875	10,421	67,886	-62,558
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-7,124	1,208	7,245	10,163	-9,851